Documented in an LDA filing dated Oct 19, 2018
Sourced institutional rolesLDA lobbying records
MARTI THOMAS
MARTI THOMAS appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Prior government service disclosed in an LDA filing; exact dates not reported
Deputy Assistant Secretary, Tax and Budget, Treasury; Acting and Asst Secretary, Legislative Affairs, Treasury; Assistant to COS, House Majority Leader;Floor Aide and Executive Floor Asst, House Majority Leader
Federal government
Inspect source ↗Federal LDA filings
Lobbying Activity
CVS HEALTH INC3rd Quarter (July 1 - Sep 30) 2018
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Judiciary issues related to the drug supply chain Issues related to the company's merger with Aetna Issues related to the "Gag Rule" bill
LDA filing ↗CVS HEALTH INC2nd Quarter (Apr 1 - June 30) 2018
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals H.R.2212 - CREATES Act of 2017 Judiciary issues related to the drug supply chain
LDA filing ↗CVS HEALTH INC1st Quarter (Jan 1 - Mar 31) 2019
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements
LDA filing ↗CVS HEALTH INC4th Quarter (Oct 1 - Dec 31) 2018
Registrant: BOCKORNY GROUP, INC. · Pharmacy
Issues related to PBM's Issues related to drug supply chain Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Judiciary issues related to the drug supply chain Issues related to the company's merger with Aetna Issues related to the "Gag Rule" bill Issues relating to dialysis reimbursements
LDA filing ↗